Learn More
Unexpected drug efficacy or resistance is poorly understood in cancers because of the lack of systematic analyses of drug response profiles in cancer tissues of various genotypic backgrounds. The recent development of high‑throughput technologies has allowed massive screening of chemicals and drugs against panels of heterogeneous cancer cell lines. In(More)
  • 1